WO1999035243A3 - Extension of cellular lifespan, methods and reagents - Google Patents
Extension of cellular lifespan, methods and reagents Download PDFInfo
- Publication number
- WO1999035243A3 WO1999035243A3 PCT/US1999/000682 US9900682W WO9935243A3 WO 1999035243 A3 WO1999035243 A3 WO 1999035243A3 US 9900682 W US9900682 W US 9900682W WO 9935243 A3 WO9935243 A3 WO 9935243A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reagents
- methods
- extension
- vivo
- cellular lifespan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99903059A EP1045697A2 (en) | 1998-01-12 | 1999-01-12 | Extension of cellular lifespan, methods and reagents |
AU23172/99A AU759437B2 (en) | 1998-01-12 | 1999-01-12 | Extension of cellular lifespan, methods and reagents |
JP2000527629A JP2002500040A (en) | 1998-01-12 | 1999-01-12 | Extending cell life, methods and reagents |
CA002315265A CA2315265A1 (en) | 1998-01-12 | 1999-01-12 | Extension of cellular lifespan, methods and reagents |
IL13710199A IL137101A0 (en) | 1998-01-12 | 1999-01-12 | Extension of cellular lifespan, methods and reagents |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7122098P | 1998-01-12 | 1998-01-12 | |
US60/071,220 | 1998-01-12 | ||
US7145598P | 1998-01-13 | 1998-01-13 | |
US60/071,455 | 1998-01-13 | ||
US6365798A | 1998-04-21 | 1998-04-21 | |
US09/063,657 | 1998-04-21 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1999035243A2 WO1999035243A2 (en) | 1999-07-15 |
WO1999035243A3 true WO1999035243A3 (en) | 1999-09-16 |
WO1999035243A9 WO1999035243A9 (en) | 1999-10-28 |
Family
ID=27370514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/000682 WO1999035243A2 (en) | 1998-01-12 | 1999-01-12 | Extension of cellular lifespan, methods and reagents |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1045697A2 (en) |
JP (1) | JP2002500040A (en) |
AU (1) | AU759437B2 (en) |
CA (1) | CA2315265A1 (en) |
IL (1) | IL137101A0 (en) |
WO (1) | WO1999035243A2 (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6572845B2 (en) * | 1998-10-16 | 2003-06-03 | Burt D. Ensley | Recombinant hair treatment compositions |
IL143328A0 (en) * | 1998-11-25 | 2002-04-21 | Genetica Inc | Methods and reagents for increasing proliferative capacity and preventing replicative senescence |
ATE514772T1 (en) * | 1999-08-05 | 2011-07-15 | Abt Holding Co | MULTIPOTENT ADULT STEM CELLS AND METHOD FOR ISOLATION THEREOF |
US8252280B1 (en) | 1999-08-05 | 2012-08-28 | Regents Of The University Of Minnesota | MAPC generation of muscle |
US8609412B2 (en) | 1999-08-05 | 2013-12-17 | Regents Of The University Of Minnesota | Mapc generation of lung tissue |
AU2006202072B2 (en) * | 1999-08-05 | 2010-12-09 | Abt Holding Company | Multipotent adult stem cells and methods for isolation |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US10638734B2 (en) | 2004-01-05 | 2020-05-05 | Abt Holding Company | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
EP1103615A1 (en) * | 1999-11-25 | 2001-05-30 | Universite De Geneve | Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
FR2810046B1 (en) * | 2000-06-07 | 2004-09-10 | Neurotech | PROCESS FOR CONDITIONAL IMMORTALIZATION OF CELLS AND PROTEIN CONSTRUCTIONS FOR ITS IMPLEMENTATION |
US20020045219A1 (en) * | 2000-08-02 | 2002-04-18 | Whitehead Institute For Biomedical Research | Production of human monoclonal antibodies |
WO2002016657A1 (en) | 2000-08-24 | 2002-02-28 | Sierra Sciences, Inc. | Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
IL157332A0 (en) | 2001-02-14 | 2004-02-19 | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof | |
US7211435B2 (en) | 2001-06-21 | 2007-05-01 | Sierra Sciences, Inc. | Telomerase expression repressor proteins and methods of using the same |
EP1472340A4 (en) * | 2002-02-05 | 2006-11-08 | Rappaport Family Inst For Res | Lineage committed stem cells selected for telomerase promoter activity |
US20060228798A1 (en) | 2002-11-27 | 2006-10-12 | Catherine Verfaillie | Homologous recombination in multipotent adult progenitor cells |
JP5583882B2 (en) | 2003-06-23 | 2014-09-03 | テロメラーゼ アクティベーション サイエンシーズ, インコーポレイテッド | Compositions and methods for increasing telomerase activity |
US9248088B2 (en) | 2003-06-25 | 2016-02-02 | Telomerase Activation Sciences, Inc. | Compositions and methods for skin conditioning |
US8426200B2 (en) | 2003-07-02 | 2013-04-23 | Regents Of The University Of Minnesota | Neuronal differentiation of stem cells |
JP2009511061A (en) | 2005-10-14 | 2009-03-19 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | Differentiation of non-embryonic stem cells into cells with pancreatic phenotype |
AU2007321928A1 (en) | 2006-11-24 | 2008-05-29 | Regents Of The University Of Minnesota | Endodermal progenitor cells |
AU2009205886B2 (en) | 2008-01-18 | 2015-08-27 | Katholieke Universiteit Leuven | Stem cell aggregates and methods for making and using |
US9057051B2 (en) | 2008-10-31 | 2015-06-16 | Katholieke Universiteit Leuven | Optimized methods for differentiation of cells into cells with hepatocyte progenitor phenotypes, cells produced by the methods, and methods of using the cells |
ES2661310T3 (en) | 2009-03-09 | 2018-03-28 | Bioatla, Llc | Mirac proteins |
HUE030253T2 (en) | 2009-05-18 | 2017-04-28 | Telomerase Activation Sciences Inc | Compositions and methods for increasing telomerase activity |
DK2536830T3 (en) | 2010-02-16 | 2019-10-21 | Ultimovacs As | POLYPEPTIDES |
CA3128483A1 (en) | 2010-05-12 | 2011-11-17 | Abt Holding Company | Modulation of splenocytes in cell therapy |
US9090878B2 (en) | 2010-06-17 | 2015-07-28 | Katholieke Universiteit Leuven | Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells |
EP2402038B1 (en) * | 2010-07-02 | 2016-05-25 | Fundación Centro Nacional De Investigaciones Oncológicas Carlos III | Telomerase reverse transcriptase for protection against ageing |
AU2011293440B2 (en) | 2010-08-24 | 2016-05-05 | Katholieke Universiteit Leuven | Non-static suspension culture of cell aggregates |
KR102161726B1 (en) | 2013-04-12 | 2020-10-06 | 사베리오 라프란체스카 | Improving organs for transplantation |
CN114657281A (en) * | 2020-12-22 | 2022-06-24 | 中国科学院动物研究所 | Endogenous virus as marker of aging degree and application of endogenous virus as aging intervention target |
CN114601747A (en) * | 2022-03-07 | 2022-06-10 | 广州市万千粉丝化妆品有限公司 | Application of nucleoprotein telomerase with functions of promoting growth of protein and RNA, prolonging cell telomere and proliferating in cosmetics |
WO2024075819A1 (en) * | 2022-10-07 | 2024-04-11 | Agc株式会社 | Virus vector production method employing cell |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995013382A1 (en) * | 1993-11-12 | 1995-05-18 | Geron Corporation | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
WO1996040868A1 (en) * | 1995-06-07 | 1996-12-19 | Cold Spring Harbor Laboratory | Essential oligonucleotides of vertebrate telomerase |
US5830644A (en) * | 1992-05-13 | 1998-11-03 | Geron Corporation | Method for screening for agents which increase telomerase activity in a cell |
-
1999
- 1999-01-12 WO PCT/US1999/000682 patent/WO1999035243A2/en active IP Right Grant
- 1999-01-12 IL IL13710199A patent/IL137101A0/en unknown
- 1999-01-12 CA CA002315265A patent/CA2315265A1/en not_active Abandoned
- 1999-01-12 AU AU23172/99A patent/AU759437B2/en not_active Ceased
- 1999-01-12 EP EP99903059A patent/EP1045697A2/en not_active Withdrawn
- 1999-01-12 JP JP2000527629A patent/JP2002500040A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830644A (en) * | 1992-05-13 | 1998-11-03 | Geron Corporation | Method for screening for agents which increase telomerase activity in a cell |
WO1995013382A1 (en) * | 1993-11-12 | 1995-05-18 | Geron Corporation | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
WO1996040868A1 (en) * | 1995-06-07 | 1996-12-19 | Cold Spring Harbor Laboratory | Essential oligonucleotides of vertebrate telomerase |
Non-Patent Citations (6)
Title |
---|
AUTEXIER C ET AL: "RECONSTITUTION OF HUMAN TELOMERASE ACTIVITY AND IDENTIFICATION OF AMINIMAL FUNCTIONAL REGION OF THE HUMAN TELOMERASE RNA", EMBO JOURNAL, vol. 15, no. 21, 1 November 1996 (1996-11-01), pages 5928 - 5935, XP002056802 * |
H. VAZIRI AND S. BENCHIMOL: "RECONSTITUTION OF TELOMERASE ACTIVITY IN NORMAL HUMAN CELLS LEADS TO ELONGATION OF TELOMERES AND EXTENDED REPLICATIVE LIFE SPAN", CURRENT BIOLOGY, vol. 8, no. 5, 26 February 1998 (1998-02-26), pages 279 - 282, XP002107653 * |
J. WANG ET AL.: "MYC ACTIVATES TELOMERASE", GENES & DEVELOPMENT, vol. 12, 1998, pages 1769 - 1774, XP002107654 * |
K. FUJIMOTO AND M. TAKAHASHI: "TELOMERASE ACTIVITY IN HUMAN LEUKEMIC CELL LINES IS INHIBITED BY ANTISENSE PENTADECADEOXYNUCLEOTIDES TARGETED AGAINST C-MYC MRNA", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 241, 1997, pages 775 - 781, XP002107655 * |
K. HIYAMA ET AL.: "ACTIVATION OF TELOMERASE IN HUMAN LYMPHOCYTES AND HEMATOPOIETIC PROGENITOR CELLS", J. IMMUNOLOGY, vol. 155, no. 8, 1995, pages 3711 - 3715, XP002107651 * |
S.L. WEINRICH ET AL.: "RECONSTITUTION OF HUMAN TELOMERASE WITH THE TEMPLATE RNA COMPONENT HTR AND THE CATALYTIC PROTEIN SUBUBIT HTRT", NATURE GENETICS, vol. 17, 1997, pages 498 - 502, XP002107652 * |
Also Published As
Publication number | Publication date |
---|---|
EP1045697A2 (en) | 2000-10-25 |
AU2317299A (en) | 1999-07-26 |
WO1999035243A2 (en) | 1999-07-15 |
IL137101A0 (en) | 2001-06-14 |
JP2002500040A (en) | 2002-01-08 |
CA2315265A1 (en) | 1999-07-15 |
AU759437B2 (en) | 2003-04-17 |
WO1999035243A9 (en) | 1999-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999035243A3 (en) | Extension of cellular lifespan, methods and reagents | |
WO2000031238A3 (en) | Methods and reagents for increasing proliferative capacity and preventing replicative senescence | |
WO2002018638A3 (en) | Detection of cyp2d6 polymorphisms | |
DE69917716D1 (en) | Protein-deamidative enzyme, gene coding therefor, method for the production and use thereof | |
DE69939945D1 (en) | METHOD OF ISOLATING STEM CELLS | |
DE60021160D1 (en) | Protein-deamidating enzyme, gene encoding it, enzyme-producing microorganism, process for the preparation and use thereof | |
ZA981762B (en) | Nucleic acid molecules encoding enzymes having fructosyl polymerase activity. | |
WO2003012119A3 (en) | Nucleic acid amplification method | |
WO2004029219A3 (en) | Cell-based rna interference and related methods and compositions | |
WO2004042029A3 (en) | Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use | |
AU3199699A (en) | Modified nucleotides and methods useful for nucleic acid sequencing | |
DE69823026D1 (en) | INTEGRATED RESONANT MICROSTRUCTURE SENSOR FOR HIGH TEMPERATURES | |
EP1173614A4 (en) | Antisense oligonucleotides comprising universal and/or degenerate bases | |
WO2002103046A3 (en) | Happier mapping | |
DE69501228T2 (en) | Ascorbate oxidase, gene coding therefor, process for its preparation and reagent composition using the same | |
ID26028A (en) | POLYMERIZATION OBSERVATION COMPOSITION, POLYMERIZATION OBSERVATION AND POLYMERIZATION OBSERVATION METHOD | |
ID26690A (en) | CATALYST COMPOSITION, THE METHOD OF MAKING IT AND THE METHOD OF PURIFICATION OF ACID | |
WO2000029623A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
EP1102992A4 (en) | Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease | |
DE69534685D1 (en) | TRANSFERASE AND AMYLASE, METHOD FOR PRODUCING THESE ENZYMES, THEIR USE AND THE CODING GENES | |
WO2004042006A3 (en) | Amylases, nucleic acids encoding them and methods for making and using them | |
WO2003048308A3 (en) | Thermus brockianus nucleic acid polymerases | |
AU2002352902A8 (en) | Thermus thermophilus nucleic acid polymerases | |
EP1081221A4 (en) | Endo-beta-n-acetylglucosaminidase gene | |
AU6372099A (en) | Method for the generation of dna fingerprints |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 137101 Country of ref document: IL |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/8-8/8, DRAWINGS, REPLACED BY NEW PAGES 1/11-11/11; DUE TO LATE TRANSMITTAL BY THE RECEIVINGOFFICE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2315265 Country of ref document: CA Ref country code: CA Ref document number: 2315265 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 23172/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999903059 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 527629 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999903059 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999903059 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 23172/99 Country of ref document: AU |